Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Ensuring that the ocular surface is optimized is a key step before cataract surgery, but it is also important in the context of glaucoma. Two physicians discussed the importance of addressing the ocular surface and what to do prior to glaucoma surgery and combined cataract/glaucoma procedures.
IOP elevation following intravitreal injections can be divided into short-term and long-term elevations. Short-term elevations are common, and some studies have estimated that they affect greater than 90% of patients.
➤ New device for bladeless goniotomy ➤ FDA approves the first at-home digital vision test ➤ Alcon to acquire Aerie Pharmaceuticals ➤ Study: Phase 2 trial for investigational dry eye therapy meets primary endpoint ➤ ASCRS news and events
➤ Long-term safety, efficacy data reported from standalone MIGS procedure ➤ Positive clinical data in ongoing trial for investigational thyroid eye disease treatment ➤ Bioengineered cornea restores vision in 20 people ➤ ASCRS news and events
➤ FDA approves first standalone MIGS device ➤ Phase 3 clinical study results for inflammation, pain management nanosuspension ➤ Phase 2a clinical trial begins for investigational MGD treatment ➤ Registry created to collect data on canaloplasty ➤ ASCRS news and events
➤ FDA approves new multifocal IOL ➤ FDA approves new biosimilar ➤ First patient dosed in Phase 3 trial for investigational dry eye drug ➤ First patient dosed in Phase 2 trial investigating sustained delivery for wet AMD ➤ First patient dosed in Phase 2 study of small molecule to treat diabetic retinopathy ➤ Enrollment complete in Phase 3 trials evaluating myopia progression therapy ➤ Study emphasizes need for earlier glaucoma screening in black patients ➤ Company acquires diagnostic technology ➤ ASCRS news and events
➤ Small-aperture IOL receives FDA approval ➤ First patient enrolled in new LASIK trial ➤ Safety of sustained-release intravitreal implant confirmed ➤ Dosing complete in Phase 1/2a trial for injectable wet AMD therapy ➤ First patient dosed in light-activated optogenetic monotherapy study ➤ Phase 2 study for investigational new immunomodulator to treat dry eye disease ➤ Partnership created to develop tissue implant therapies ➤ ASCRS news and events
➤ Machine assesses cardiovascular risk with retinal scan ➤ FDA requests more info for BLA for bevacizumab ➤ Genetic variables affect NMOSD treatment ➤ Study: 12-month results from canaloplasty-trabeculotomy procedure ➤ Topline results from Phase 3 pivotal trial evaluating pupil-modulating drug ➤ ASCRS news and events
➤ Topline results from Phase 3 pivotal trial evaluating mydriasis drug ➤ First person dosed in Phase 3 trial for first-in-class dry eye candidate ➤ Phase 2 study of a novel glaucoma drop targeting non-traditional outflow ➤ Digital vision screening platform with machine learning ➤ Alcon to acquire dry eye drop and inflammation/pain drop ➤ New issue online ➤ ASCRS news and events
➤ Phase 4 results evaluating intravitreal implant ➤ Interim results for X-linked retinitis pigmentosa treatment ➤ New non-contact glaucoma laser treatment receives CE mark ➤ Companies collaborate for regenerative dry eye therapy ➤ Complimentary MIGS video series ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.